Normal
22nd - 23rd June 2023

MarketsandMarkets Precision Medicine Conference

Boston, USA

Scrutinizing the Innovative Research on Personalized Therapy

A neoteric breakthrough in Precision Medicine has been acclaimed as the steppingstone in disease prediction and prevention strategies. This integral change in our approach to medication therapy has federal efforts in developing the ‘’Hyperindividualised’’ therapy while taking into account the genetic patterns, drug responses, lifestyle and cultural environment.

The substantial research in disease treatment strategies have contributed to developing target drugs, study of novel biomarkers in disease diagnosis, regenerative medicine leading to customized therapeutic approaches. Precision Medicine will not only have an impact on targeted treatment delivery but the prospect of studying the biological complexity of disorders associated with high mortality rate and cost-efficient treatment plans.

MarketsandMarkets is delighted to announce its Precision Medicine Conference scheduled to be held on 22nd - 23rd June 2023 in San Diego, USA. The conference will assimilate diverse sessions on Comprehensive Overview of Precision Medicine, Novel horizons in biomarker strategies, Current Multi Omics analysis, Artificial Intelligence and Machine Learning, Gene expression Profiling in Precision Medicine, Contributions of Tissue engineering and Regenerative Medicine in target drug discovery. The event encompasses networking sessions, panel discussions, solutions, and services catering to precision medicine. The conference will constellate a full spectrum of experts, leaders, and stakeholders to share a board prospective the novel research and development in Precision Medicine. 

WHAT TO EXPECT

Key highlights

  1. Novel horizons in biomarker strategies,
  2. Liquid biopsy-based disease detection
  3. Current Multi Omics analysis
  4. Artificial Intelligence and Machine Learning
  5. Gene expression Profiling in Precision Medicine
  6. Contributions of Tissue engineering and Regenerative Medicine in target drug discovery.
  7. Radiomics and Pathomics in disease prediction and prognosis

Why attend?

  • To share and exchange the recent trends and techniques in Personalized Medicine
  • Quality insights and cohesiveness of key issues and obstacles experienced by the healthcare providers while implementing Precision Medicine
  • Discover the different avenues in patient centric care
  • Access wide range of novel applications, innovative research, regulatory and policy development
  • Opportunity for one-on-one networking and extend professional competency with experts ranging from Government, Industry, Technology, Research and Healthcare providers
  • Be a part of the conversations via panel discussion with great lineup of experts

Who should attend?

  • Industry: Pharma/Therapeutic Companies/Start Up’s
  • CEOs, CMO’s, CSO’s, COO’s, Presidents, Vice Presidents, Directors, Managing Directors, Head of Departments, Executive Leaders, Pharmacists, Oncologists, Immunologists, Geneticists, Principal Scientists, Big Data Scientists, Business Development, Regulatory and Policy Advisors, Diagnostic Laboratory Professionals, Global Leaders.
  • Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology
  • Academics: Universities, Research Institutes, Hospitals
  • Head of Departments, Professors, Lecturers, Senior Scientists, Researchers, Bioinformaticians
  • Departments: Oncology, Personalized medicine, Immunology, Molecular Biology, Genetics and genomic medicine, Molecular Medicine, Pharmacogenomics, Biotechnology

CONFERENCE AGENDA
Enquire Now

Sponsor/Exhibit Delegate
CONFERENCE SPEAKERS
Speakers
Shannon Muir
Shannon Muir
Co-director of the California Initiative to Advance Precision Medicine in the California Governor’s Office of Planning and Research,
Schott Cecilia
Schott Cecilia
Global head Precision Medicine Diagnostics Novartis,
Manish Kohli
Manish Kohli
, Huntsman Cancer Institute
Laura Dillon
Laura Dillon
Head of Translational Biomarkers, Parthenon Therapeutics
Please contact [email protected] for speaking opportunity
PARTNERS
Media Partners
example-image

IoT Global Network

LOCATION
Boston, USA
About the Hotel

PAST EVENT GALLERY